Rajarshi Guha

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	11532	4836
h-endeksi	53	33
i10-endeksi	97	66

1200

600

300

900

2006200720082009201020112012201320142015201620172018201920202021202220232024202564 97 168 235 294 390 449 423 555 631 648 745 913 962 1043 1105 938 781 817 152

Genel erişim

Tümünü görüntüle

65 makale

1 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Marc FerrerDirector, NIHmail.nih.gov üzerinde doğrulanmış e-posta adresine sahip
Egon WillighagenTGX, NUTRIM, Maastricht University/NL, ORCID:0000-0001-7542-0286, https://social.edu.nl/@egonwmaastrichtuniversity.nl üzerinde doğrulanmış e-posta adresine sahip
David WildProfessor, Indiana Universityiu.edu üzerinde doğrulanmış e-posta adresine sahip
Christoph SteinbeckFriedrich-Schiller-University Jenauni-jena.de üzerinde doğrulanmış e-posta adresine sahip
James IngleseADST Laboratory, NCATS, Adjunct Investigator NHGRI, NIHmail.nih.gov üzerinde doğrulanmış e-posta adresine sahip
Lesley MathewsNovartisnovartis.com üzerinde doğrulanmış e-posta adresine sahip
Michele CeribelliStaff Scientist, Division of Pre-Clinical Innovation, NCATS, NIHnih.gov üzerinde doğrulanmış e-posta adresine sahip
Kelli WilsonNational Center for Advancing Translational Science (NCATS)nih.gov üzerinde doğrulanmış e-posta adresine sahip
John H. Van DrieVan Drie Research LLCvandrieresearch.com üzerinde doğrulanmış e-posta adresine sahip
Ola SpjuthProfessor at Department of Pharmaceutical Biosciences, Uppsala Universityfarmbio.uu.se üzerinde doğrulanmış e-posta adresine sahip
Noel SouthallAstraZenecaastrazeneca.com üzerinde doğrulanmış e-posta adresine sahip
Louis M. StaudtNational Cancer Institutemail.nih.gov üzerinde doğrulanmış e-posta adresine sahip
Andreas BenderKhalifa University; University of Cambridge; Pangea Bio; Universitatea Babeș-Bolyai; UMF Clujku.ac.ae üzerinde doğrulanmış e-posta adresine sahip
Stefan KuhnLecturerut.ee üzerinde doğrulanmış e-posta adresine sahip
Ajit JadhavPfizerpfizer.com üzerinde doğrulanmış e-posta adresine sahip
Eugen BuehlerAstraZenecaastrazeneca.com üzerinde doğrulanmış e-posta adresine sahip
YIBIN YANGFox Chase Cancer Centerfccc.edu üzerinde doğrulanmış e-posta adresine sahip
Marlon PierceIndiana Universityiu.edu üzerinde doğrulanmış e-posta adresine sahip
Geoffrey FoxProfessor of Computer Science, University of Virginia, Biocomplexity Institutevirginia.edu üzerinde doğrulanmış e-posta adresine sahip
Nina JeliazkovaIdeaconsult Ltd.ideaconsult.net üzerinde doğrulanmış e-posta adresine sahip

Takip et

Rajarshi Guha

Vertex Pharmaceuticals

vrtx.com üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Chemistry Cheminformatics Bioinformatics Machine Learning Visualization


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma Y Yang, AL Shaffer, NCT Emre, M Ceribelli, M Zhang, G Wright, W Xiao, ... Cancer cell 21 (6), 723-737, 2012	616	2012
Recent developments of the chemistry development kit (CDK)-an open-source java library for chemo-and bioinformatics C Steinbeck, C Hoppe, S Kuhn, M Floris, R Guha, EL Willighagen Current pharmaceutical design 12 (17), 2111-2120, 2006	580	2006
The Chemistry Development Kit (CDK) v2. 0: atom typing, depiction, molecular formulas, and substructure searching EL Willighagen, JW Mayfield, J Alvarsson, A Berg, L Carlsson, ... Journal of cheminformatics 9, 1-19, 2017	500	2017
The Blue Obelisk—interoperability in chemical informatics R Guha, MT Howard, GR Hutchison, P Murray-Rust, H Rzepa, ... Journal of chemical information and modeling 46 (3), 991-998, 2006	499	2006
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells LA Mathews Griner, R Guha, P Shinn, RM Young, JM Keller, D Liu, ... Proceedings of the National Academy of Sciences 111 (6), 2349-2354, 2014	437	2014
Unexplored therapeutic opportunities in the human genome TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ... Nature reviews Drug discovery 17 (5), 317-332, 2018	421	2018
High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy SA Hasson, LA Kane, K Yamano, CH Huang, DA Sliter, E Buehler, ... Nature 504 (7479), 291-295, 2013	411	2013
Structure− activity landscape index: identifying and quantifying activity cliffs R Guha, JH Van Drie Journal of chemical information and modeling 48 (3), 646-658, 2008	376	2008
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ... PLoS Pathog 12 (7), e1005763, 2016	318	2016
Chemical informatics functionality in R R Guha Journal of Statistical Software 18, 1-16, 2007	306	2007
RNA polymerase II regulates topoisomerase 1 activity to favor efficient transcription L Baranello, D Wojtowicz, K Cui, BN Devaiah, HJ Chung, KY Chan-Salis, ... Cell 165 (2), 357-371, 2016	301	2016
PAX3–FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability BE Gryder, ME Yohe, HC Chou, X Zhang, J Marques, M Wachtel, ... Cancer Discovery 7 (8), 884-899, 2017	293	2017
What are we ‘tweeting’about obesity? Mapping tweets with topic modeling and Geographic Information System D Ghosh, R Guha Cartography and geographic information science 40 (2), 90-102, 2013	278	2013
Pharos: collating protein information to shed light on the druggable genome DT Nguyen, S Mathias, C Bologa, S Brunak, N Fernandez, A Gaulton, ... Nucleic acids research 45 (D1), D995-D1002, 2017	277	2017
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors M Ceribelli, PN Kelly, AL Shaffer, GW Wright, W Xiao, Y Yang, ... Proceedings of the National Academy of Sciences 111 (31), 11365-11370, 2014	229	2014
Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives KC Bulusu, R Guha, DJ Mason, RPI Lewis, E Muratov, YK Motamedi, ... Drug discovery today 21 (2), 225-238, 2016	216	2016
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome GW Rhyasen, L Bolanos, J Fang, A Jerez, M Wunderlich, C Rigolino, ... Cancer cell 24 (1), 90-104, 2013	215	2013
On exploring structure–activity relationships R Guha In silico models for drug discovery, 81-94, 2013	204	2013
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses R Jossé, SE Martin, R Guha, P Ormanoglu, TD Pfister, PM Reaper, ... Cancer research 74 (23), 6968-6979, 2014	201	2014
Navigating structure–activity landscapes J Bajorath, L Peltason, M Wawer, R Guha, MS Lajiness, JH Van Drie Drug Discovery Today 14 (13-14), 698-705, 2009	193	2009

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar